Intellectual Property
Mar. 28, 2012
Appellate court to reconsider gene case in light of Prometheus
In the wake of its decision that the laws of nature cannot be patented, the U.S. Supreme Court ordered an appellate court to reconsider its decision that two genes linked to breast and ovarian cancer are eligible for patent protection.
Daily Journal Staff Writer
In the wake of its decision that the "laws of nature" cannot be patented, the U.S. Supreme Court Monday ordered an appellate court to reconsider its decision that two genes linked to breast and ovarian cancer are eligible for patent protection.
Attorneys involved in the case, and outside legal observers, said they are not surprised by the decision, which followed the court's 9-0 ruling...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In